Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Nanolattix Biotechnology Co., Ltd.

Clinical trials sponsored by Nanolattix Biotechnology Co., Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New PET tracer could light up hidden cancers Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet recruiting 1

New drug T320 targets tough tumors in early trial

Disease control Not yet recruiting

This early-stage study tests a new drug called T320 in 150 people with advanced solid tumors that have not responded to standard treatments. The main goals are to check the drug's safety, find the best dose, and see if it can shrink tumors. Participants receive T320 every two wee…

Phase 1 • Sponsor: Nanolattix Biotechnology Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 09:07 UTC